Inhibitor/Activator
| Cat.No. | Name | Information |
|---|---|---|
| M14117 | YKL-05-099 | YKL-05-099 is a salt-inducible kinase (SIK) inhibitor. YKL-05-099 binds to SIK1 and SIK3 with IC50s of ~10 and ~30 nM, respectively. YKL-05-099 has slightly less potent SIK2-inhibitory (IC50=40 nM). |
| M11237 | ARN-3236 | Arn-3236 is a selective inhibitor of salt-induced kinase 2 (SIK2) with an IC50 value of <1 nM, 21.63 nM and 6.63 nM against SIK2, SIK1 and SIK3, respectively. It has antitumor activity. |
| M9395 | HG-9-91-01 | HG-9-91-01 is a potent and highly selective salt-inducible kinase (SIK) inhibitor with IC50s of 0.92 nM, 6.6 nM and 9.6 nM for SIK1, SIK2 and SIK3 respectively. |
| M42055 | SIKs-IN-1 | SIKs-IN-1 inhibitor. |
| M42054 | MR22 | MR22 is a potent pan-SIK (salt-inducible kinase) inhibitor. |
| M42053 | SIK2-IN-1 | SIK2-IN-1 is a potent SIK2 inhibitor over other AMPK kinases. |
| M40967 | GLPG3970 | GLPG3970 is a first-in-class salt-inducible kinase SIK2/SIK3 inhibitor for studies related to inflammatory and autoimmune diseases such as psoriasis. |
| M29326 | YKL-06-062 | YKL-06-062 is a second-generation salt-inducible kinase (SIK) inhibitor with an IC50 of 2.12 nM/1.40 nM/2.86 nM for SIK1, SIK2 and SIK3, respectively. |
| M28491 | MRT199665 | MRT199665 is a potent and ATP-competitive, selective MARK/SIK/AMPK inhibitor with IC50s of 2/2/3/2 nM, 10/10 nM, and 110/12/43 nM for MARK1/MARK2/MARK3/MARK14, AMPKα1/AMPKα2, and SIK1/SIK2/SIK3, respectively. MRT199665 causes apoptosis in MEF2C-activated human acute myeloid leukemias (AML) cells. MRT199665 inhibits the phosphorylation of SIK substrate CRTC3 at S370. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
